North Shore-LIJ Health System, Department of Medicine, Division of Nephrology, Hofstra North Shore-LIJ School of Medicine, Great Neck, NY 11021, USA.
Kidney Int. 2012 Jun;81(12):1167-71. doi: 10.1038/ki.2012.138. Epub 2012 Apr 25.
Monitoring the quality of dialysis care has long been a component of the Medicare ESRD program. As part of the 2008 Medicare Improvements for Patients and Providers Act (MIPPA), Congress mandated the Quality Incentive Program (QIP), which linked measures of care quality to payments. The legislation embraced the idea that this linkage of federal money to performance would encourage the purchase of greater 'value.' The first 2 program years for the QIP use a simple scoring methodology and a limited scope of quality metrics. For payment year 2014 (performance period calendar year 2012), the program changes substantially, with an expanded number of quality measures and a more complex scoring methodology. In this article, we describe the program structure, quality measures, scoring system, and financial impact.
长期以来，透析护理质量监测一直是医疗保险终末期肾病（ESRD）计划的一个组成部分。作为 2008 年医疗保险患者和提供者改善法案（MIPPA）的一部分，国会授权实施质量激励计划（QIP），该计划将护理质量措施与支付款项挂钩。该立法采纳了这样一种观点，即联邦资金与绩效挂钩将鼓励购买更多的“价值”。QIP 的前 2 个计划年度使用简单的评分方法和有限的质量指标范围。对于 2014 年的付款年度（2012 年的绩效周期日历年度），该计划发生了重大变化，增加了更多的质量指标和更复杂的评分方法。在本文中，我们将介绍该计划的结构、质量指标、评分系统和财务影响。
